- Home
- IDE vs CATX Comparison
IDE vs CATX Comparison
Compare IDE & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDE
- CATX
- Stock Information
- Founded
- IDE 2010
- CATX 1983
- Country
- IDE United States
- CATX United States
- Employees
- IDE N/A
- CATX N/A
- Industry
- IDE Finance/Investors Services
- CATX Medical/Dental Instruments
- Sector
- IDE Finance
- CATX Health Care
- Exchange
- IDE Nasdaq
- CATX Nasdaq
- Market Cap
- IDE 163.0M
- CATX 182.9M
- IPO Year
- IDE N/A
- CATX N/A
- Fundamental
- Price
- IDE $11.36
- CATX $2.57
- Analyst Decision
- IDE
- CATX Strong Buy
- Analyst Count
- IDE 0
- CATX 9
- Target Price
- IDE N/A
- CATX $12.63
- AVG Volume (30 Days)
- IDE 33.5K
- CATX 749.8K
- Earning Date
- IDE 01-01-0001
- CATX 05-12-2025
- Dividend Yield
- IDE 8.83%
- CATX N/A
- EPS Growth
- IDE N/A
- CATX N/A
- EPS
- IDE N/A
- CATX N/A
- Revenue
- IDE N/A
- CATX $1,471,000.00
- Revenue This Year
- IDE N/A
- CATX N/A
- Revenue Next Year
- IDE N/A
- CATX N/A
- P/E Ratio
- IDE N/A
- CATX N/A
- Revenue Growth
- IDE N/A
- CATX N/A
- 52 Week Low
- IDE $8.61
- CATX $1.60
- 52 Week High
- IDE $10.46
- CATX $16.55
- Technical
- Relative Strength Index (RSI)
- IDE 72.90
- CATX 53.32
- Support Level
- IDE $11.21
- CATX $2.34
- Resistance Level
- IDE $11.33
- CATX $2.94
- Average True Range (ATR)
- IDE 0.13
- CATX 0.28
- MACD
- IDE -0.00
- CATX 0.00
- Stochastic Oscillator
- IDE 83.61
- CATX 55.95
About IDE Voya Infrastructure Industrials and Materials Fund of Beneficial Interest
Voya Infrastructure, Industrials and Materials Fund is a diversified closed-end management investment company. The primary objective of this investment fund is to achieve total return by combining current income, capital gains, and capital appreciation. To achieve this objective, the fund invests in companies that own and/or operate infrastructure facilities in the infrastructure sector, as well as in a broad range of companies in the industrials and materials sectors that the Sub-Adviser believes will benefit from infrastructure building, renovation, expansion, and utilization.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.